Submit Deal

ALCAMI CORPORATION

Deals Overview

Total Deals5

Valued Deals1

Total Value£15M

Avg. Deal Size£15M

Market Context

Senior Management

Patrick Walsh
Chairman and CEO
George Van Kula
CEO
Bill Humphries
CEO

Deals (5)

Service Providers

Relationships

Portfolio

Team

Sort

United States

Pharmaceuticals

PrivateAcquisitionMajorityPrivate Equity

target

Tripharm Services

bidder

Alcami Corporation

value n/a

3 dealmakers

Netherlands

Pharmaceuticals

AcquisitionDomesticPrivateMajority

target

Alcami Weert

bidder

MERCACHEMSYNCOM

value n/a

8 dealmakers

United States

Pharmaceuticals

PrivateAcquisitionMajorityDomestic

target

Alcami Corporation (wisconsin Facility)

bidder

Sterling Pharma

£15m

18 dealmakers

United States

Pharmaceuticals

Private EquityAcquisitionCross BorderMajorityPrivate

target

Alcami Corporation

bidder

Gho Capital Partners

value n/a

26 dealmakers

United States

Industrial Distribution

MajorityDomesticPrivateAcquisition

target

Pacific Pharmaceutical Services

bidder

Alcami Corporation

value n/a

13 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.